Letter to the Editor. The treatment of cerebral cavernous malformation–related hemorrhage using β-blocker medication

Lei Zhao MD
View More View Less
  • Tangdu Hospital, The Fourth Military Medical University, Xi’an, China
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

If the inline PDF is not rendering correctly, you can download the PDF file here.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Lei Zhao: conrad03037@gmail.com.

INCLUDE WHEN CITING Published online February 15, 2019; DOI: 10.3171/2018.11.JNS183257.

Disclosures The author reports no conflict of interest.

  • 1

    Duris K, Lipkova J, Jurajda M: Cholinergic anti-inflammatory pathway and stroke. Curr Drug Deliv 14:449457, 2017

  • 2

    Goldberg J, Jaeggi C, Schoeni D, Mordasini P, Raabe A, Bervini D: Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study. J Neurosurg [epub ahead of print June 15, 2018. DOI: 10.3171/2017.12.JNS172404]

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Hernandez-Martin A, Torrelo A: Cutaneous and paravertebral infantile hemangioma: report of two cases. Pediatr Dermatol 25:193195, 2008

  • 4

    Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A: Propranolol for severe hemangiomas of infancy. N Engl J Med 358:26492651, 2008

  • 5

    Miquel J, Bruneau B, Dupuy A: Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol. J Am Acad Dermatol 70:e83e84, 2014

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    Moschovi M, Alexiou GA, Stefanaki K, Tourkantoni N, Prodromou N: Propranolol treatment for a giant infantile brain cavernoma. J Child Neurol 25:653655, 2010

  • 7

    Reinhard M, Schuchardt F, Meckel S, Heinz J, Felbor U, Sure U, : Propranolol stops progressive multiple cerebral cavernoma in an adult patient. J Neurol Sci 367:1517, 2016

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8

    Zabramski JM, Kalani MY, Filippidis AS, Spetzler RF: Propranolol treatment of cavernous malformations with symptomatic hemorrhage. World Neurosurg 88:631639, 2016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Zhang J, Shi K, Li Z, Li M, Han Y, Wang L, : Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage. FASEB J 32:220229, 2018

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 1

    Berti I, Marchetti F, Skabar A, Zennaro F, Zanon D, Ventura A: Propranolol for cerebral cavernous angiomatosis: a magic bullet. Clin Pediatr 53:189190, 2014

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2

    de Graaf M, Raphael MF, Breugem CC, Knol MJ, Bruijnzeel-Koomen CAFM, Kon M, : Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group. J Plast Reconstr Aesthet Surg 66:17321740, 2013

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3

    Duris K, Lipkova J, Jurajda M: Cholinergic anti-inflammatory pathway and stroke. Curr Drug Deliv 14:449457, 2017

  • 4

    Gross BA, Du R: Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis. J Neurosurg 126:10791087, 2017

  • 5

    Horne MA, Flemming KD, Su IC, Stapf C, Jeon JP, Li D, : Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol 15:166173, 2016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Miquel J, Bruneau B, Dupuy A: Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol. J Am Acad Dermatol 70:e83e84, 2014

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7

    Moschovi M, Alexiou GA, Stefanaki K, Tourkantoni N, Prodromou N: Propranolol treatment for a giant infantile brain cavernoma. J Child Neurol 25:653655, 2010

  • 8

    Raphaël MF, de Graaf M, Breugem CC, Pasmans SGMA, Breur JMPJ: Atenolol: a promising alternative to propranolol for the treatment of hemangiomas. J Am Acad Dermatol 65:420421, 2011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Reinhard M, Schuchardt F, Meckel S, Heinz J, Felbor U, Sure U, : Propranolol stops progressive multiple cerebral cavernoma in an adult patient. J Neurol Sci 367:1517, 2016

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Zabramski JM, Kalani MY, Filippidis AS, Spetzler RF: Propranolol treatment of cavernous malformations with symptomatic hemorrhage. World Neurosurg 88:631639, 2016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Zhang J, Shi K, Li Z, Li M, Han Y, Wang L, : Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage. FASEB J 32:220229, 2018

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 561 451 8
Full Text Views 40 15 0
PDF Downloads 42 13 0
EPUB Downloads 0 0 0